Section of Physical Medicine & Rehabilitation, Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Oncologist. 2023 Feb 8;28(2):180-186. doi: 10.1093/oncolo/oyac229.
Prognosis has a vital role for patients with cancer undergoing palliative rehabilitation in acute inpatient rehabilitation. This study aimed to identify the proportion of patients who survived <2 months after discharge and the associated prognostic factors.
This was a secondary analysis of a retrospective study of 163 consecutive patients admitted to acute inpatient rehabilitation from September 1, 2017, to February 28, 2018 at a cancer center. Baseline demographics, clinical characteristics, and putative prognostic factors, including Activity Measure for Post-Acute Care (AM-PAC) functional scores, were analyzed.
Of 163 patients, 27 (17%; 95% CI, 11-23) died within 60 days of discharge. These patients were more likely to be male (OR = 2.83; 95% CI, 1.16-6.92; P = .017); have longer hospital stays (OR = 1.02; 95% CI, 1-1.04; P = .015); receive ≥ weekly packed red blood cell (OR = 5.31; 95% CI, 1.86-15.1; P = .003) or platelet (OR = 4.57; 95% CI, 1.44-14.5; P = .014) transfusions; have lower AM-PAC daily activity scores upon discharge (OR = 0.90; 95% CI, 0.83-0.97; P = .006); and have lower AM-PAC basic mobility scores upon admission (OR = 0.91; 95% CI, 0.85-0.98; P = .018) and discharge (OR = 0.88; 95% CI, 0.82-0.94; P = <.001). Multivariate analysis showed that the male sex (OR = 2.71; 95% CI, 1.03-7.15; P = .037) was independently associated with ≤2 months survival, whereas AM-PAC basic mobility score at admission of >33 (OR = 0.24, 95% CI, 0.07-0.79; P = .022) was less likely.
Approximately 1 in 6 patients who completed acute inpatient rehabilitation died within 2 months of discharge, had poorer baseline functional status, and were less likely to regain function than those who lived longer.
在急性住院康复中,接受姑息性康复治疗的癌症患者的预后对患者至关重要。本研究旨在确定出院后 2 个月内存活的患者比例以及相关的预后因素。
这是对 2017 年 9 月 1 日至 2018 年 2 月 28 日在癌症中心接受急性住院康复治疗的 163 例连续患者进行的回顾性研究的二次分析。分析了基线人口统计学、临床特征和假定的预后因素,包括康复后活动测量(AM-PAC)功能评分。
在 163 例患者中,有 27 例(17%;95%CI,11-23)在出院后 60 天内死亡。这些患者更可能是男性(OR=2.83;95%CI,1.16-6.92;P=0.017);住院时间更长(OR=1.02;95%CI,1-1.04;P=0.015);接受≥每周一次的浓缩红细胞(OR=5.31;95%CI,1.86-15.1;P=0.003)或血小板(OR=4.57;95%CI,1.44-14.5;P=0.014)输注;出院时 AM-PAC 日常活动评分较低(OR=0.90;95%CI,0.83-0.97;P=0.006);入院时 AM-PAC 基本活动评分较低(OR=0.91;95%CI,0.85-0.98;P=0.018)和出院时(OR=0.88;95%CI,0.82-0.94;P<0.001)。多变量分析显示,男性(OR=2.71;95%CI,1.03-7.15;P=0.037)是与≤2 个月生存相关的独立因素,而入院时 AM-PAC 基本活动评分>33 (OR=0.24,95%CI,0.07-0.79;P=0.022)的可能性较低。
在完成急性住院康复治疗的患者中,约有 1/6 在出院后 2 个月内死亡,这些患者的基线功能状态较差,恢复功能的可能性较小。